Recce Pharmaceuticals Ltd (ASX:RCE)

Recce Pharmaceuticals Revenue

Recce Pharmaceuticals had revenue of 412.04K AUD in the half year ending December 31, 2025, a decrease of -82.70%. This brings the company's revenue in the last twelve months to 974.56K, down -89.84% year-over-year. In the fiscal year ending June 30, 2025, Recce Pharmaceuticals had annual revenue of 7.51M with 49.33% growth.

• Revenue (ttm): 974.56K
• Revenue Growth: -89.84%
• P/S Ratio: 118.69
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 115.67M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	7.51M	2.48M	49.33%
Jun 30, 2024	5.03M	663.14K	15.19%
Jun 30, 2023	4.37M	1.28M	41.50%
Jun 30, 2022	3.08M	1.45M	88.41%
Jun 30, 2021	1.64M	515.66K	45.97%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jun 22, 2026

Data Sources Report a data error